06:32
A Phase I trial of DSP-5336, a novel menin inhibitor, in the treatment of AML
4981057 Menin Mp3 & Mp4
06:32
02:11
Phase I results of the menin inhibitor enzomenib in patients with R/R acute leukemia
01:14
Promising novel agents in AML: menin inhibitors
02:13
New Therapies in AML - Menin Inhibitor Revumenib (SNDX-5613) | Eytan M. Stein, MD | ASH 2022 #AML
02:22
Updates on menin inhibitors for acute leukemia and the pushback of revumenib approval
01:41
The emerging role of menin inhibitors in the treatment of NPM1-mutated and KMT2A-rearranged R/R AML
02:06
The future of menin inhibition in AML: combination strategies
00:47
Menin inhibitors in AML
01:41
Phase I trial of the menin inhibitor JNJ-75276617 in patients with acute leukemia
01:38
The potential of menin inhibitors in specific molecular subsets of AML & ALL